NEXEN TIRE Strengthens Global Market Penetration with Locally Customized Products
Launching ultra-high-performance (UHP) N’FERA Sport in U.S. and strengthening distribution competitiveness through…
PM-International expands child sponsorships to 8,000 with 2.88 million donation
SCHENGEN, Luxembourg, Dec. 15, 2025 /PRNewswire/ -- Global support for children in…
Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime
HUNTSVILLE, Ala., Dec. 15, 2025 /PRNewswire/ -- Titomic Limited (ASX: TTT), a…
MSI unveils its year-end holiday sale with unbeatable festive offers on its top laptop series
~ Exclusive bundle offers across MSI Brand Stores, Authorized Physical Resellers, Croma…
Beko reaches its seventh consecutive year with the highest S&P Global Corporate Sustainability Assessment score in the DHP Household Durables Industry
ISTANBUL, Dec. 15, 2025 /PRNewswire/ -- Beko**, a global leader in home…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
Citius TransNet Investment Trust Files Draft Offer Document with SEBI for Rs 1,340 Cr InvIT
MUMBAI, India, Dec. 11, 2025 /PRNewswire/ -- Mumbai-based Citius TransNet Investment Trust,…
Jaipur's Coolest Creative Festival Is Back: SHIFT 2025 Takes Over Birla Auditorium with Comedy, Crafts & Culture
SHIFT is Jaipur's ultimate, uber-cool New Gen Creative Festival. An arts and…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
